CHRISTIAN PLAZA: Open Payments
NPI 1477039733 · NEWBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 22 payments from 9 companies in 2025. Trend: 2023 $797 · 2024 $601 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $348 |
| Alkermes, Inc. | 4 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| ABBVIE INC. | 1 | $29 |
| Lilly USA, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Indivior Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: Yeztugo, LYBALVI, Descovy, ARISTADA, CAPLYTA, Auvelity, VRAYLAR, MOUNJARO.
Industry payments across NY — which companies pay providers there.
